Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
0 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Design Therapeutics, Inc.’s names, not what it holds today.
Patents granted
0
by type: not read, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
22
7 of them in 2025
Names they are printed under
1
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name1 counted
Design Therapeutics, Inc. its own name
named as the applicant on its applications, in US
22 published
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Dec 4, 2025 | 2025/0368628 | METHODS AND COMPOUNDS FOR MODULATING INHERITED GENETIC DISEASES | Pharmaceuticals | Design Therapeutics, Inc. |
| Sep 25, 2025 | 2025/0295632 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Pharmaceuticals | Design Therapeutics, Inc. |
| Sep 4, 2025 | 2025/0276997 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Organic fine chemistry | Design Therapeutics, Inc. |
| May 22, 2025 | 2025/0163028 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Pharmaceuticals | Design Therapeutics, Inc. |
| May 8, 2025 | 2025/0144226 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Pharmaceuticals | Design Therapeutics, Inc. |
| May 8, 2025 | 2025/0144221 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Organic fine chemistry | Design Therapeutics, Inc. |
| Apr 3, 2025 | 2025/0109132 | COMPOUNDS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA | Pharmaceuticals | Design Therapeutics, Inc. |
| Oct 31, 2024 | 2024/0360105 | PROCESS FOR POLYAMIDE SYNTHESIS | Organic fine chemistry | Design Therapeutics, Inc. |
| Aug 15, 2024 | 2024/0269290 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Biotechnology | Design Therapeutics, Inc. |
| May 23, 2024 | 2024/0166693 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | Organic fine chemistry | Design Therapeutics, Inc. |
What it applied for, 2024 to 2025: Pharmaceuticals 7 · Organic fine chemistry 6 · Biotechnology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.